Hyperliquid Strategies (NASDAQ:PURR) Shares Down 7.3% – Should You Sell?

Hyperliquid Strategies Inc (NASDAQ:PURRGet Free Report) shares traded down 7.3% during trading on Friday . The stock traded as low as $5.40 and last traded at $5.4250. 2,908,789 shares changed hands during mid-day trading, a decline of 24% from the average session volume of 3,845,903 shares. The stock had previously closed at $5.85.

Analysts Set New Price Targets

A number of research firms have commented on PURR. Cantor Fitzgerald lifted their price objective on shares of Hyperliquid Strategies from $5.00 to $6.00 and gave the stock an “overweight” rating in a report on Thursday, February 12th. Weiss Ratings started coverage on Hyperliquid Strategies in a research report on Monday, March 2nd. They set a “sell (e)” rating on the stock. Wall Street Zen upgraded Hyperliquid Strategies to a “hold” rating in a research report on Saturday, February 21st. Finally, Chardan Capital raised their target price on Hyperliquid Strategies from $8.15 to $8.45 and gave the company a “buy” rating in a research note on Thursday, February 12th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Hyperliquid Strategies presently has a consensus rating of “Hold” and a consensus price target of $7.23.

Get Our Latest Report on PURR

Hyperliquid Strategies Price Performance

The company has a market capitalization of $644.64 million, a PE ratio of -0.56 and a beta of 1.58.

Hyperliquid Strategies (NASDAQ:PURRGet Free Report) last released its earnings results on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter. The business had revenue of $0.50 million for the quarter.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of PURR. Paradigm Operations LP bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $20,327,000. Galaxy Group Investments LLC bought a new stake in Hyperliquid Strategies during the fourth quarter worth approximately $15,167,000. Pantera Capital Partners LP acquired a new position in Hyperliquid Strategies in the fourth quarter worth approximately $14,545,000. Feynman Point Asset Management LLC acquired a new position in Hyperliquid Strategies in the fourth quarter worth approximately $14,431,000. Finally, 683 Capital Management LLC bought a new position in shares of Hyperliquid Strategies in the fourth quarter valued at $5,660,000. 9.45% of the stock is owned by institutional investors and hedge funds.

Hyperliquid Strategies Company Profile

(Get Free Report)

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

Read More

Receive News & Ratings for Hyperliquid Strategies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperliquid Strategies and related companies with MarketBeat.com's FREE daily email newsletter.